In whom and how to prevent glucocorticoid-induced osteoporosis

Best Pract Res Clin Rheumatol. 2005 Dec;19(6):1039-64. doi: 10.1016/j.berh.2005.07.002.

Abstract

Glucocorticoid use is widespread in medicine. While it is often life-saving, side-effects are well known. The most common side-effect is osteoporosis. Today we have therapies with proven efficacy for the prevention of vertebral fractures and bone loss. Consequently recognition of glucocorticoid-induced osteoporosis is extremely important given the availability of effective therapy.

Publication types

  • Review

MeSH terms

  • Bone Density / drug effects
  • Bone Density Conservation Agents / therapeutic use*
  • Calcitonin / therapeutic use
  • Calcium, Dietary / therapeutic use
  • Diphosphonates / therapeutic use
  • Fluorides / therapeutic use
  • Glucocorticoids / adverse effects*
  • Hormone Replacement Therapy
  • Humans
  • Life Style
  • Osteoporosis / chemically induced*
  • Osteoporosis / physiopathology
  • Osteoporosis / prevention & control*
  • Risk Factors
  • Vitamin D / therapeutic use

Substances

  • Bone Density Conservation Agents
  • Calcium, Dietary
  • Diphosphonates
  • Glucocorticoids
  • Vitamin D
  • Calcitonin
  • Fluorides